Latest immunotherapy news
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC
posted April 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy
posted March 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Related Articles
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine Monthly Specialist Briefings
Stay Connected
